Navigation Links
New Symptom-free STD on the Rise in US and Australia

A new symptom-free sexually transmitted disease (STD) has surpassed Neisseria gonorrhea in prevalence among young adults in the US. In Australia too it is becoming a big menace, researchers say .

The new infection is named Mycoplasma genitalium and was first identified in the 1980s. It can cause inflammation of the urethra (the urinary passage from the bladder), in men, and inflammation of the cervix and the lining of the uterus in women, possibly leading to infertility.

In the current study, researchers at the University of Washington, Seattle, tested 1714 women and 1218 men between the ages of 18 and 27 years participating in Wave III of the National Longitudinal Study of Adolescent Health.

Results of the study are published in the American Journal of Public Health.

The investigators found Mycoplasma genitalium infection in 1.0 percent of the participants.

In contrast, the prevalence of gonorrhea was 0.4 percent. The prevalence of chlamydia infection was 4.2 percent.

The prevalence of Mycoplasma genitalium infection was 11 times higher among individuals living with a sexual partner, seven times higher among blacks and four times higher among those who use condoms during sex.

None of the genitalium-positive individuals had any discharge.

"Many M. genitalium infections are asymptomatic, like chlamydial infections,'' principal investigator Dr. Lisa Manhart said.

"However, unlike chlamydia, it is probably too soon to recommend widespread screening for M. genitalium.''

There are no commercial tests to detect the organism, she explained.

Furthermore, she and her colleagues note in their report that it is not clear "whether M. genitalium-infected persons require or benefit from treatment - and if so, what antimicrobial therapy should be recommended.''


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. Australia awaits US FDA reports on ADHD drugs
11. No booster vaccine For every fourth child in Australia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: